General MedicationsORALGeneric
DOFETILIDE
DOFETILIDE
Standard Dose
0.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview DOFETILIDE is listed in Drugs@FDA under application 215323 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient DOFETILIDE Form and strength CAPSULE;ORAL - 0.5MG Sponsor RK PHARMA Submission history Latest submission status date: 2022-04-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview DOFETILIDE is listed in Drugs@FDA under application 215323 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DOFETILIDE Form and strength CAPSULE;ORAL - 0.5MG Sponsor RK PHARMA Submission history Latest submission status date: 2022-04-14 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.